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The skin is a complex and dynamic ecosystem. It may act as physical barrier to bar the invasion of 
foreign pathogens while concomitantly providing home to commensals bacteria, fungi and viruses. 
These microbes were known as microbiota. Over a human’s life span, skin cells, immune cells, and 
microbiota will integrate to maintain homeostasis of skin’s physiology and immune barrier, both 
under healthy conditions and also under stresses (infection and wounding). Shifts in the normal 
microbiota may cause diseases such as atopic dermatitis and psoriasis even though pathophysiology 
of these conditions is still unknown.  
 





Normal microbial flora denotes population 
of microorganisms that inhabit the skin and 
mucous membranes of healthy normal skin.1 
Skin became home to millions of bacteria, fungi 
and virus that compose the skin microbiota.2 
Humans have co-evolved with  microbes that 
create complex, adaptive ecosystem with 
habitat-specific nature that are finely attuned to 
relentlessly changing host physiology.3 Skin 
and mucous membranes harbors two groups of 
microorganism: (1) resident microbiota 
consists of regular microorganisms regularly 
found in a given area at a given age and (2) 
transient microbiota consists of non-pathogenic 
microorganism or potentially pathogenic which 
resides in skin or mucous membranes for hours, 
days or weeks. Study showed that normal 
microbiota is the first line of defense against 
pathogen, toxin degradation and immune 
system maturation.1 Dysbiosis may cause skin 
diseases such as acne vulgaris, atopic 
dermatitis, psoriasis and cancer.1,3 
2. Composition of Skin Microbiota 
 
Skin may differ commensal, non-dangerous 
microorganisms from pathogenic 
microorganisms, even though continually 
exposed to them in large numbers. But this 
selectivity mechanism is still unclear.1 
Assembly process of skin microbiota begins 
during birth and proceeds primarily according 
to body site over several weeks. Microbiota 
shifts notably during puberty and adulthood. 
Despite the skin’s continuous exposure to the 
environment, microbial composition remains 
stable over time. This suggests that mutually 
beneficial interactions exist among commensal 
microbes and between microbes and the host.4 
Several studies showed the role of microbiota 
in human’s health and diseases.5  
Skin is home to myriad microbial 
communities residing in skin surface as well as 
follicles and sebaceous glands. Skin surface has 
varied microenvironments with different pH, 
temperature, humidity, sebum contents and 
topography.1 Skin surface is cool, acidic, and 
Majalah Kedokteran Sriwijaya,  




bathed in sweat with only sebum and stratum 
corneum peptides as well as lipids for source of 
nutrients. Moreover, sweat is salt-laden and 
consists of antibacterial molecules, such as free 
fatty acids and antimicrobial peptides (AMPs). 
Nevertheless, humans and their commensal 
microbial communities have coevolved to 
provide mutual benefit.6 Studies from different 
skin locations which became the usual 
predilections for microbial infections revealed 
role of skin physiology as microbial community 
predictor.1 Grice et al divided bacterial skin 
microbiota into 4 phyllum comprised of 
Actinobacteria, Firmicutes, Proteobacteria and 
Bacteroides. Three most common genera 
consist of Corynebacteria, Propinibacteria and 
Staphylococci.7 Each community has distinct 
predilections according to skin 
microenvironments. Sebaceous sites were 
dominated by lipophilic Propionibacterium 
species whereas humid environments were 
dominated by Staphylococcus and 
Corynebacterium species. Less humid sites 
were dominated by Staphylococcus, 
Propinibacterium, Micrococcus, 
Corynebacterium, Enhydrobacter and 
Streptococcus species.1,2,8 One of the major 
genus of skin bacteria was Corynebacterium. 
Most of Corynebacterium species in skin did 
not cause diseases. This species’ role was 
shown to affect host’s health. Corynebacterium 
accolens, one of the normal skin bacteria, may 
inhibit the growth of Streptococcus 
pneumoniae. This was in part caused by 
Corynebacterial lipase that hydrolize triolein to 
oleic acid, that may inhibit pneumococcal 
growth.4 Other dominant group were negative-
coagulase Staphylococcus species especially S. 
epidermidis. Even though of its opportunistic 
pathogen nature, S. epidermidis and S. hominis 
may secrete antimicrobial peptide which could 
eliminate S. aureus. Studies regarding S. 
epidermidis showed evidence of skin resident 
bacteria’s active role in stimulating host 
immunity and activating specific immune cell 
populations. Few strains of S. epidermidis may 
induce activation of S. epidermidis-specific IL-
17+CD8+ T cells, which provide protection 
against skin infections via keratinocyte 
induction to produce AMPs.4 
Fungi comprised the smallest number of 
microbiotas in skin. Despite its small 
populations, fungi may have a role in microbial 
diversification and maintain the equilibrium of 
microbiota community as well as host’s health.9 
Fungi from Malassezia genus dominated the 
torso and upper extremities while lower 
extremities were colonized by varied 
combination of Malassezia spp., Aspergillus 
spp., Cryptococcus spp., Rhodotorula spp., 
Epicoccum spp.2,9 Findley et al analyzed fungi 
community of 10 adults from 14 skin sites. 
These sites were chosen based on physiological 
characteristics and sites of predilection for 
fungal-associated dermatologic diseases 
including middle upper back, external auditory 
canal, retroauricular crease, occiput, glabella, 
inguinal crease, manubrium, nares, antecubital 
fossa, volar forearm, hypothenar palm, plantar 
heel, toenail, and toe web (webspace between 
3rd   and 4th toes). Researchers found 
significant difference between bacterial and 
fungal microbiota in human skin. Variations of 
bacterial microbiota were classified by skin 
physiology (sebaceous, humid and less humid 
sites) and lipophilic bacteria (Corynebacterium, 
Propionibacterium, Turicella) as well as 
Staphylococcal species. Furthermore, fungi 
microbiota was classified by skin locations 
(head, upper extremities and torso), which 
created discrete groups. Malassezia species 
dominated retroauricular crease, nares and 
occiput. Plantar heels were found with the most 
fungi variations including Malassezia, 
Aspergillus, Cryptococcus, Rhodotorula, 
Epicoccum.9  
Colonization by eukaryotic DNA viruses is 
more individually-specific. Common gene 
markers between viruses is yet to be found. This 
means virus community diversification may 
only be detected by purified viral-like particles 
or shotgun metagenomics sequencing. 
Moreover, RNA virus can only be sequenced by 
RNA sequencing, which never be done before 
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from skin sample.2 Besides bacteriophage, 
DNA virus core has yet to be found in every 
individual. Eukaryotic virus may also play a 
role in skin diseases especially after the 
discovery of Merkel cell polyomavirus, an 
oncovirus that may cause rare but aggressive 
skin cancer. Skin shotgun metagenomics may 
define the expansion and relative number of 
bacterial, fungal and virus component in human 
skin.2,10 (Picture 1). 
 
3. Microbiota in Skin Immunity  
 
The skin has immune surveillance system 
from complex combinations of epithelial cell 
tissue, lymphocyte and antigen-presenting 
cells. Skin immune system may affect innate 
and adaptive immunity in stimulating immune 
response. Acute skin damage releases ligand 
which activate keratinocyte and triggers 
inflammatory mediators release.4,6 Immune 
system evolved with resident microbiota in skin 
to maintain commensal equilibrium and 
pathogen elimination. Effective 
communication between skin microbiota, 
epithelial cell and immune system is vital for 
optimal mechanism. Keratinocyte may 
recognize microorganisms especially pathogen-
associated molecular patterns (PAMPs), via 
pattern recognition receptors (PRRs). Bond 
between PAMPs and PRRs which triggered 
innate immune system (AMP), may eliminate 
and inactivate microorganisms including 
bacteria, fungi and parasite.2 Skin microbial 
controlled the expression of several innate 
immune factors such as AMP. Epithelial cell 
antimicrobial peptides (AMPs) derived from 
several protein family such as cathelicidin and 




      
Picture 1. Normal skin microbiota 7 
Majalah Kedokteran Sriwijaya,  
Th. 52 Nomor 1, January 2020 
 
 236 
Some of these molecules may rapidly 
eliminate or inactivate skin pathogens such as 
Gram positive and Gram-negative bacteria, 
fungi, virus and parasite. Expressions of 
molecules were controlled by microbiota such 
as Cutibacterium species or produced by 
certain microbes (e.g. Cutibacterium species 
peptide and AMPs by S. epidermidis).4,6 Most 
of Corynebacterium species in skin microbiota 
may not inflict diseases. Cell wall of 
Corynebacterium consist of lipoglycan which 
comprised of lipomannan and 
lipoarabinomannan, located inside plasma 
membrane and have long-chain 
oligosaccharide. Lipomannan and 
lipoarabinomannan were ligand for host’s 
glycan receptor such as toll-like receptors 
(TLRs) and type-C lectin receptor, which 
trigger pro- or anti-inflammatory response. 
Other dominant group were negative-coagulase 
Staphylococcus species especially S. 
epidermidis. Staphylococcus species in skin 
triggers interaction between microbes which 
may be beneficial to host. As an example, S. 
epidermidis and S. hominis secreted AMP to 
eliminate S. aureus. Other products of S. 
epidermidis which was lipoteichoic acid, may 
reduce inflammation and trigger wound healing 
via the ability to bind innate toll-like receptor 2 
(TLR-2) immune receptor.4  
Exact mechanism of AMP, especially 
induced by microbiota in microbial community 
is still unclear but this relationship plays a vital 
role in skin microbial ecology. Skin microbiota 
may control the expression level of interleukin-
1 (IL-1), cytokine involved in initiating and 
amplifying immune response. Chain 
consequences of skin microbiota role in innate 
immunity was the increase of lymphocyte 
activation followed by adaptive immunity. Skin 
microbiota act as endogen adjuvant in skin 
immune system. Skin commensal microbiota 
may modulate local T-cell function via the 
ability to arrange innate immune environment 
and IL-1 production.  
These caused potential increase of 
cytokine production which involved in host 
defense and inflammatory diseases such as IL-
17A and interferon-γ (IFN-γ) by dermal T-
cells.6 Flora of the skin may control immune 
homeostasis and autonomically respond to 
infection. Skin microbiota may control immune 






Picture 2. Dialogue between skin microbiota and immune system
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compartmentalization of immune response 
evolved as a mechanism to limit adjuvant 
properties of commensals and unwanted 
consequences of systemic inflammatory 
responses. Recognition process of commensal 
and antigen products by immune system and 
cellular mediators involved in dialogue 
between skin microbiota and immunity is still 
unknown.  
One hypothesis described skin dendritic 
cells surrounding the rich commensal 
communities were associated with appendages 
such as the hair follicle and may be able to 
capture microbes or microbial products. 
Furthermore, microbial secreted metabolites or 
their downstream products may be able to 
diffuse and be captured or sensed by 
neighboring cells (Picture 2).6 
 
 
4. Microbiota and Skin Diseases 
 
Interactions between resident microbial 
community may prevent colonization of 
pathogenic bacteria.2 Skin diseases were related 
to microbiota changes or dysbiosis.11 Excessive 
bathing were reported with disrupting skin 
barrier that caused skin irritation and changes in 
skin microbiota. Cosmeceutical products, 
makeup and moisturizers were suspected in 
modification of skin microbiota. Use of 
overrated antibiotics caused the emergence of 
resistant strain of pathogenic microorganisms. 
Aside from extrinsic factors, intrinsic factors 
such as sebum overproduction during puberty, 
induced over-colonization of Propinibacterium 
acnes and dysequilibrium of skin microbiota.7,8  
Acne vulgaris is a prevalent, chronic 
inflammatory disease in teenagers, linked to P. 
acnes. Findings of P. acnes in most patients but 
only causing acne in handful of patients, give 
rise to importance of further studies in host’s 
genetic, barrier or immunity defects and 
environments. As an example, increase of 
sebum secretions correlate with severity of 
acne.2 Classical feature of teenage acne vulgaris 
is sebaceous hyperplasia and lipid release into 
the follicular lumen, which leads to a clogged 
pore. This process results in follicular wall 
rupture, triggering neutrophil influx and pustule 
formation. Further studies in animal model is 
needed, to compare genomic strain of P. acnes 
as commensal and pathogen microbe of acne 
vulgaris.6 
Atopic dermatitis is a chronic 
inflammatory disease affected by several 
factors including epidermal barrier disturbance, 
immune cell activation and changes in skin 
microorganism community. Vulnerability 
against this disease was linked to mutations in 
more than 30 gene locus including skin barrier 
protein filaggrin. Longitudinal study in 
pediatric case of atopic dermatitis showed the 
increase of Staphylococcus spp species 
especially S. aureus and S. epidermidis, during 
episodic exacerbation and disease’s worsening. 
Correlation between S. aureus and atopic 
dermatitis during exacerbation was 
documented well but functional role of 
Staphylococcal bacteria in triggering atopic 
dermatitis is still unclear and prompted further 
longitudinal study.2,6  
Psoriasis is a chronic inflammatory disease 
related with T-cells. In psoriatic plaque, the 
increased number of Streptococcus spp. colony 
and the decrease of P. acnes were found. 
Psoriatic plaque was characterized by increased 
infiltration of activated T-cells which produce 
inflammatory cytokines especially IL-17A, that 
tightly correlated with psoriasis pathogenesis. 
Several implications of pathogenic IL-17A 
include amplifications of several inflammatory 
pathways in the skin which cause keratinocyte 
hyperproliferation and emergence of psoriatic 
lesion. Barrier permeability alterations and 
larger commensal exposure may cause more 
severe inflammatory process. Ability of 
microbiota to control skin immunity is 
suspected in triggering and worsening the 
disease.6  
Majalah Kedokteran Sriwijaya,  






Human skin microbiota is a complex and 
dynamic ecosystem. Studies showed the role of 
microbiota as home to commensals bacteria and 
immune barrier against pathogen. Dysbiosis 
may cause acne vulgaris, atopic dermatitis and 
psoriasis. More research needed to increase 
knowledge regarding skin microbiota.  
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